Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies-Reference-Cited by-同舟云学术

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

Published:2024-07 Issue:3 Volume:14 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Staal Diederik P.¹^ORCID,Hendriks Paul M.²³^ORCID,van Thor Mitch C. J.¹,van de Groep Liza D.¹,van den Toorn Leon M.³,Mulder Berend‐Jan M.¹,Chandoesing Prewesh P.³,Kauling Robert M.²,Boerman Sanne⁴,van den Bosch Annemien E.²,Mager Johannes J.⁴,Boomars Karin A.³,Post Martijn C.¹⁵

Affiliation:

1. Department of Cardiology St. Antonius Hospital Nieuwegein/Utrecht the Netherlands

2. Department of Cardiology, Erasmus MC University Medical Centre Rotterdam Rotterdam the Netherlands

3. Department of Respiratory Medicine, Erasmus MC University Medical Centre Rotterdam Rotterdam the Netherlands

4. Department of Respiratory Medicine St. Antonius Hospital Nieuwegein/Utrecht the Netherlands

5. Department of Cardiology University Medical Center Utrecht Utrecht the Netherlands

Abstract

AbstractTherapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH‐specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

Funder

Cilag

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12419

Reference17 articles.

1. The pathophysiology of chronic thromboembolic pulmonary hypertension

2. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension

3. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

4. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

5. Does combination therapy work in chronic thromboembolic pulmonary hypertension?